Key result
An 83-year-old female developed fatal prosthetic aortic valve endocarditis four months after undergoing transapical aortic valve implantation.
Case Report (n=1)
No
Highlights the risk and fatal consequence of infective endocarditis following transcatheter aortic valve implantation.
Answers are grounded in this paper and cite their sources.
Fatal endocarditis can occur months after transapical TAVI; this case leaves open optimal surveillance and prevention strategies.
An 83-year-old patient underwent a transapical aortic valve implantation at our institution. Four months later, she was readmitted to our institution because of fever and heart failure. A prosthetic aortic valve endocarditis was diagnosed. Because of the high surgical risk, surgery was refused and the patient died shortly after the diagnosis. We briefly discuss the implications of this finding in the prevention of infective endocarditis after transcatheter aortic valve implantation.
No takes yet. Share an insight, caveat, or question.
Carnero et al. (2010) conducted a case report in Prosthetic aortic valve endocarditis (n=1). Transapical aortic valve implantation was evaluated on Prosthetic aortic valve endocarditis and death. An 83-year-old female developed fatal prosthetic aortic valve endocarditis four months after undergoing transapical aortic valve implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: